🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Decoding Lenskart FY25 numbers

EntrackrEntrackr · 1m ago
Decoding Lenskart FY25 numbers
Medial

Eyewear brand Lenskart has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) in order to raise Rs 2,150 crore via a fresh issue. The company made a sharp turnaround from FY24 and turned profitable, driven by robust growth in revenue and controlled spending across key verticals. Lenskart’s operating revenue grew 23% to Rs 6,653 crore in FY25 from Rs 5,428 crore in FY24, according to its restated financial statement given in DRHP. The bulk of the company’s revenue came from the sale of goods such as prescription eyewear, sunglasses, contact lenses, and accessories which rose 23% to Rs 6,360 crore. Revenue from services such as memberships, home eye check-ups, and training grew 27% to Rs 133 crore, supported by the expansion of its Lenskart Gold programs, which grew to 68 lakh members by March 2025. Other operating income consisted of lease income, scrap sales, website licence fees, and support charges which remained steady at Rs 160 crore. Geographically, revenue from India rose 27% to Rs 4,015 crore. Lenskart added 282 new stores and saw its annual transacting customer base rise 23% to 99 lakh, while eyewear unit sales surged 30% to 2 crore. International markets contributed Rs 2,638 crore, up 17% from FY24; the brand expanded its overseas footprint with 52 new stores, growing its international customer base to 25 lakh. On the expense front, employee benefit expenses emerged as the largest cost component, which rose 27% to Rs 1,379 crore in FY25, followed by material costs which increased 20% to Rs 2,134 crore. Marketing costs also saw a 27% jump to Rs 448 crore. Meanwhile, commission and incentives fell slightly by 4% to Rs 733 crore. Depreciation expenses stood at Rs 797 crore, up 19% from the previous year. Overall, total costs rose 19% to Rs 6,619 crore in FY25 as compared to Rs 5,550 crore in FY24. This combination of steady revenue growth and calibrated cost management enabled Lenskart to post a net profit of Rs 297 crore in FY25, a substantial improvement from a Rs 10 crore loss a year earlier. Its ROCE and EBITDA margin stood at 6.17% and 2.27% respectively. On a unit basis, the company spent Re 0.99 to earn a Rupee of operating revenue in FY25. The company recorded current assets worth Rs 3,630 crore in FY25, including Rs 865 crore in cash and bank balances. Lenskart converted into a public company in June this year in preparation for the listing. The public offering is being managed by a consortium of investment banks, including Kotak Mahindra Capital, Citigroup, Avendus, Axis Capital, Morgan Stanley, and Intensive Fiscal Services.

Decoding Foxtale’s Series C funding round, latest valuation and captable

EntrackrEntrackr · 4m ago
Decoding Foxtale’s Series C funding round, latest valuation and captable
Medial

Foxtale, a direct-to-consumer (D2C) skincare brand, recently raised Rs 250 crore (approximately $30 million) in its Series C funding round, led by Japanese beauty products company Kose Corporation with the participation of existing investors—Z47 (formerly Matrix Partners India), Kae Capital, and Panthera Growth Partners. Entrackr has gone through its regulatory filings to decode details such as round break-up, shareholding, and current valuation. The board at Foxtale has issued 20 equity shares and 18,847 Series C compulsory convertible preference shares at an issue price of 1,32,237 each to raise Rs 250 crore or $30 million. Kose Corporation led the round with an investment of Rs 153 crore (approximately $18 million), followed by Z47 (formerly Matrix Partners India), which contributed Rs 45.95 crore (around $5.4 million). Panthera Growth Partners and Kae Capital, through the Kael Opportunities Fund, pumped in Rs 29.5 crore ($3.5 million) and Rs 21 crore ($2.5 million), respectively. According to Fintrackr’s estimates, the company’s post-money valuation has surged to Rs 1,530 crore (approximately $180 million), nearly doubling from its previous valuation of Rs 795 crore (around $93.5 million). Following the fresh allotment of the Series C round, Z47 (formerly Matrix Partners India) remains the largest external shareholder with a 19.64% stake, followed by Kae Capital at 17.35% and Panthera Growth Partners at 12.62%. New investor Kose Corporation now holds a 10% stake in the company. Founder and CEO of the company, Romita Mazumdar holds a 34.38% stake. Founded in 2021, Foxtale is an affordable skincare brand that develops products specifically formulated for Indian skin types, targeting issues such as acne, aging, and hyperpigmentation. Its products are available on the brand’s official website as well as popular marketplaces including Nykaa, Amazon, Blinkit, Flipkart, and Myntra. For the fiscal year ending FY24, the Mumbai-based D2C brand recorded a nearly six-fold increase in operating revenue to Rs 83 crore from Rs 14 crore in FY23. However, the company also reported a loss of Rs 55 crore during FY24.

Download the medial app to read full posts, comements and news.